4//SEC Filing
Wei Lin 4
Accession 0001209191-22-007065
CIK 0001761918other
Filed
Feb 2, 7:00 PM ET
Accepted
Feb 3, 7:54 PM ET
Size
7.1 KB
Accession
0001209191-22-007065
Insider Transaction Report
Form 4
Erasca, Inc.ERAS
Wei Lin
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-02-01+272,100→ 272,100 totalExercise: $11.54Exp: 2032-01-31→ Common Stock (272,100 underlying) - Other
Common Stock
2022-02-01$11.60/sh+1,562$18,123→ 314,062 total
Footnotes (2)
- [F1]Includes 1,562 shares acquired under the Erasca, Inc. employee stock purchase plan on December 15, 2021.
- [F2]1/48th of the shares subject to the option vest monthly following February 2, 2022, subject to the Reporting Person's continuous service to the Issuer on each such vesting date.
Documents
Issuer
Erasca, Inc.
CIK 0001761918
Entity typeother
Related Parties
1- filerCIK 0001872772
Filing Metadata
- Form type
- 4
- Filed
- Feb 2, 7:00 PM ET
- Accepted
- Feb 3, 7:54 PM ET
- Size
- 7.1 KB